| Dr Sanja Dacic, MD,PHD | |
|
310 Cedar Street, Ysm Brady Memorial Laboratory, New Haven, CT 06520 | |
| (203) 785-3624 | |
| Not Available |
| Full Name | Dr Sanja Dacic |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 34 Years |
| Location | 310 Cedar Street, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497727002 | NPI | - | NPPES |
| 001891077 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 70365 (Connecticut) | Secondary |
| 174400000X | Specialist | MD072759L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
Genetics play a strong part in the development of attention-deficit/hyperactivity disorder (ADHD), but the path from a gene to risk for the disorder has remained a black box to researchers.
The deleterious effects that obesity has on an individual's health and the difficulty of reversing it in adults are well-known, ranging from diabetes and heart disease to cancer.
Today Telstra officially launched a new business division, Telstra Health, and outlined its ambition to become Australia's leading provider of integrated eHealth solutions.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the European approval of its new ProMRI Pacing Systems — Evia pacemaker series and Safio S pacing leads — providing European patients the first portfolio of bradycardia systems that are compatible with Magnetic Resonance Imaging (MRI) scans under specific conditions.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
› Verified 9 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Genetics play a strong part in the development of attention-deficit/hyperactivity disorder (ADHD), but the path from a gene to risk for the disorder has remained a black box to researchers.
The deleterious effects that obesity has on an individual's health and the difficulty of reversing it in adults are well-known, ranging from diabetes and heart disease to cancer.
Today Telstra officially launched a new business division, Telstra Health, and outlined its ambition to become Australia's leading provider of integrated eHealth solutions.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the European approval of its new ProMRI Pacing Systems — Evia pacemaker series and Safio S pacing leads — providing European patients the first portfolio of bradycardia systems that are compatible with Magnetic Resonance Imaging (MRI) scans under specific conditions.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sanja Dacic, MD,PHD 310 Cedar Street Po Box 208023, Ysm Brady Memorial Laboratory, New Haven, CT 06520 Ph: (203) 785-3624 | Dr Sanja Dacic, MD,PHD 310 Cedar Street, Ysm Brady Memorial Laboratory, New Haven, CT 06520 Ph: (203) 785-3624 |
News Archive
Genetics play a strong part in the development of attention-deficit/hyperactivity disorder (ADHD), but the path from a gene to risk for the disorder has remained a black box to researchers.
The deleterious effects that obesity has on an individual's health and the difficulty of reversing it in adults are well-known, ranging from diabetes and heart disease to cancer.
Today Telstra officially launched a new business division, Telstra Health, and outlined its ambition to become Australia's leading provider of integrated eHealth solutions.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the European approval of its new ProMRI Pacing Systems — Evia pacemaker series and Safio S pacing leads — providing European patients the first portfolio of bradycardia systems that are compatible with Magnetic Resonance Imaging (MRI) scans under specific conditions.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
› Verified 9 days ago